STRO vs TPR
Sutro Biopharma (STRO) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
STRO currently screens at market cap $470.8M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the STRO and TPR stock pages for the full models.
Not investment advice.